Where does AMO Groningen B.V. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), AMO Groningen B.V. ranks #3,218 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does AMO Groningen B.V. hold?

AMO Groningen B.V. holds 116 US utility patents granted between 2015 and 2025, spanning 17 technology areas.

What is AMO Groningen B.V.'s Innovation Score?

AMO Groningen B.V. has an Innovation Score of 50.1 out of 100 (top 14% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is AMO Groningen B.V.'s patent grant rate increasing or decreasing?

AMO Groningen B.V.'s recent grant velocity is +17% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for AMO Groningen B.V.'s patents?

AMO Groningen B.V.'s patents average 14.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the AMO Groningen B.V. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

AMO Groningen B.V.

Q: What technology areas does AMO Groningen B.V. focus on?

AMO Groningen B.V.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 109 patents, ranking #45 of 3,082 assignees active in that subclass. Grants appear in 17 CPC subclasses total.

USPTO PatentsView assignee record - 116 granted patents across 17 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, AMO ranks #3,218 of 49,997 tracked US assignees by granted-patent volume, with 116 patents across 17 technology areas.

#3,218
of 49,997 US assignees by volume: Top 14%
by Innovation Score (50.1/100): 14.3
avg claims per patent: +17%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3218 · Foreign Corporation #3,218 · 116 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MID 116 grants
TOP-DECILE #3,218/49,997
PHOTO-FINISH Angel Playing Cards
CPC-FOCUS A61F · 17 areas
INNOV-PAR 50.1/100
CLAIMS-RICH 14.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +17% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Angel Playing Cards Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How AMO’s 50.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.5 pts (33%) Velocity 10.5 pts (21%) Breadth 14.6 pts (29%) Claim depth 8.6 pts (17%)

Qualcomm Incorporated · highest

85
Amdocs Development · near

50
AMO Groningen B V · this assignee

50
Datalogic USA · near

50
Indiana Mills &… · near

50
Universal Entertainm… · near

50
3D Lighting… · lowest

7

What this shows AMO's Innovation Score is 50.1/100 (top 14% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for AMO?

Each dot is one of AMO’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). AMO’s own 14.3 claims/patent is ABOVE the 13.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

AMO vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where AMO's grants concentrate

AMO Groningen B.V. is a focused PatentsView assignee: 17 CPC subclasses with 94% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2018 (15 grants) versus a trough of 5 in 2016. By volume, AMO sits between Universite DE Paris Descartes and Booz Allen Hamilton Inc..

AMO's three-year grant acceleration

From 2019–2021 to 2022–2024, AMO Groningen B.V. moved from 26 to 41 grants (1.58x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #392. See the growth leaderboard.

Universite DE Par…

117
West Pharma Servi…

117
Woodpeckers

117
Yamada Manufactur…

117
Angel Playing Car…

116
Arena Pharmaceuti…

116
Biotronik

116
Booz Allen Hamilt…

116
AMO Groningen B V ◀

116

What this shows AMO holds 116 patents at rank #3,218, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near AMO

By rank, the assignees closest to #3,218 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in AMO's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for AMO, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), AMO ranks #45 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (50 here).

Datalogic USA, Inc. 50 Universal Entertainment Corporation 50 Amdocs Development Limited 50 Indiana Mills & Manufacturing, Inc. 50

Similar claim depth

Nearest assignees by average claims per patent (14.3 here).

JRD Communication (Shenzhen) Ltd. 14.3 avg Bragi GmbH 14.3 avg SI-Bone Inc. 14.3 avg Carrier Corporation 14.3 avg

AMO's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 14% higher than 86% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

AMO Groningen B.V. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	5.2%
2016	5	4.3%
2017	11	9.5%
2018	15	12.9%
2019	11	9.5%
2020	7	6.0%
2021	8	6.9%
2022	15	12.9%
2023	15	12.9%
2024	11	9.5%
2025partial year	12	10.3%

Which technologies does AMO Groningen B.V. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 109

G02C - SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses 66

A61B - DIAGNOSIS; SURGERY; Identification 45

G02B - Optical Elements, Systems OR Apparatus 25

B29D - Producing Particular Articles From Plastics OR From Substances IN A Plastic State 15

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 8

G01M - Testing Static OR Dynamic Balance OF Machines OR STRUCTURES; Testing OF Structures OR Apparatus, NOT Otherwise Provided FOR 4

G16Z - Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields, NOT Otherwise Provided FOR 2

G01J - Measurement OF Intensity, Velocity, Spectral Content, Polarisation, Phase OR Pulse Characteristics OF Infrared, Visible OR Ultraviolet LIGHT; COLORIMETRY; Radiation Pyrometry 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 2

B62M - Rider Propulsion OF Wheeled Vehicles OR SLEDGES; Powered Propulsion OF Sledges OR ; SINGLE-TRACK; CYCLES; Transmissions Specially Adapted FOR Such Vehicles 2

G06T - Image Data Processing OR Generation, IN General 2

G05B - Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

Top 15 of 17 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

AMO Groningen B.V.'s patent record in context - here's where to go next.

AMO Groningen B.V.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 94% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #3,218 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare AMO Groningen B.V. against Universite DE Paris Descartes, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.